Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warns Of Deadly Benzocaine Risks, Label Changes Might Be On The Way

This article was originally published in The Tan Sheet

Executive Summary

Concern that products with the painkiller benzocaine are linked to rare but serious and potentially fatal adverse events prompted an FDA consumer warning and could lead to label and package changes.
Advertisement

Related Content

FDA Benzocaine Safety Alert Also Targets Pain From Public Citizen Complaint
FDA Benzocaine Safety Alert Also Targets Pain From Public Citizen Complaint
Public Citizen Attempts To Force FDA Decision On Benzocaine Petition
Public Citizen Attempts To Force FDA Decision On Benzocaine Petition
OTC Benzocaine Needs Label Warning, Indication Change – Public Citizen
OTC Benzocaine Needs Label Warning, Indication Change – Public Citizen
In Brief: CHPA Disagrees With FDA Warning; Adulterated Supplements Enforcement; DASCA Support Sought
In Brief: CHPA Disagrees With FDA Warning; Adulterated Supplements Enforcement; DASCA Support Sought
C&D’s Naturals Could Help Retain Orajel Customers After Benzocaine Warning
FDA Adds Targets To Semi-Annual Regulatory Agenda, Pushes Some Back

Topics

Advertisement
UsernamePublicRestriction

Register

PS104977

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel